Firms

Dolby Family Ventures
San Francisco, California, United States
Dolby Family Ventures is a San Francisco-based, family-backed venture investment platform founded in2014 to support frontier science and engineering. Its current strategy spans precision neuroscience, life-sciences platforms, aerospace, digital deep technology and climate. It invests at pre-seed, seed and SeriesA and selectively follows companies into later stages. Neuroscience work spans neurodegeneration, psychiatry, neurotechnology, devices and diagnostics, while life-sciences platforms include computational biology and technologies for discovering, developing and delivering medicines. The official roster publishes nine investment and operations professionals plus seven external scientific advisory board members; these advisers provide scientific evaluation rather than acting as operating employees or personal investment counterparties. March20,2026 regulator filings distinguish Dolby Family Ventures LLC, CRD313994/SEC802-122066, from affiliated Dolby Family Capital Management LLC, CRD313971/SEC802-122061. Eight disclosed legal fund vehicles across the two advisers are individually qualified; regulatory assets, gross fund assets and the Dolby family philanthropy or wealth are not fund-closing capital. The platform expressly states it is unaffiliated with Dolby Laboratories and that company’s capital. Its public portfolio identifies investments with active, IPO and acquired statuses, which are source-qualified snapshots rather than evidence of an undisclosed new round, an individual buyer ticket or unchanged current ownership. Existing imported affiliations absent from its current directory are retained with current appointment unverified rather than treated as newly confirmed staff.
- Founded
- 2014
- Type
- Venture capital
Funds8
DOLBY FAMILY VENTURES II LP——
Exact March20,2026 regulator legal vehicle; legal manager Dolby Family Ventures LLC kept distinct from other family adviser. Cash close/date undisclosed; no GAV/AUM or family endowment values as fundraising.
DOLBY FAMILY VENTURES III L.P.——
Exact March20,2026 regulator legal vehicle; legal manager Dolby Family Capital Management LLC kept distinct from other family adviser. Cash close/date undisclosed; no GAV/AUM or family endowment values as fundraising.
DOLBY FAMILY VENTURES LIFE SCIENCES L.P.——
Exact March20,2026 regulator legal vehicle; legal manager Dolby Family Capital Management LLC kept distinct from other family adviser. Cash close/date undisclosed; no GAV/AUM or family endowment values as fundraising.
DOLBY FAMILY VENTURES LP——
Exact March20,2026 regulator legal vehicle; legal manager Dolby Family Ventures LLC kept distinct from other family adviser. Cash close/date undisclosed; no GAV/AUM or family endowment values as fundraising.
DOLBY FAMILY VENTURES OPPORTUNITIES L.P.——
Exact March20,2026 regulator legal vehicle; legal manager Dolby Family Capital Management LLC kept distinct from other family adviser. Cash close/date undisclosed; no GAV/AUM or family endowment values as fundraising.
DOLBY TRUST LIFE SCIENCES L.P.——
Exact March20,2026 regulator legal vehicle; legal manager Dolby Family Capital Management LLC kept distinct from other family adviser. Cash close/date undisclosed; no GAV/AUM or family endowment values as fundraising.
DOLBY TRUST OPPORTUNITIES L.P.——
Exact March20,2026 regulator legal vehicle; legal manager Dolby Family Capital Management LLC kept distinct from other family adviser. Cash close/date undisclosed; no GAV/AUM or family endowment values as fundraising.
DOLBY TRUST VENTURES L.P.——
Exact March20,2026 regulator legal vehicle; legal manager Dolby Family Capital Management LLC kept distinct from other family adviser. Cash close/date undisclosed; no GAV/AUM or family endowment values as fundraising.
Team
![]() Reetika Bhardwaj Dolby Family Ventures, Principal | $25M$50K – $150M | Chicago, Illinois |
| $1M$300K – $3M | San Francisco Bay Area | |
![]() Doug Talbert Dolby Family Ventures, Associate (legacy imported affiliation; current appointment unverified) | $1M$100K – $5M | San Francisco Bay Area |
![]() Francesca Cignarella Dolby Family Ventures, Associate (legacy imported affiliation; current appointment unverified) | $1M$300K – $3M | San Francisco Bay Area |
![]() Andrew Krowne Dolby Family Ventures, Managing Partner | $1M$300K – $3M | San Francisco, California |
![]() Tracy Saxton Dolby Family Ventures, Managing Director (legacy imported affiliation; current appointment unverified) | $1M$300K – $3M | San Francisco, California |
![]() Michael McIntyre Dolby Family Ventures, Investor (Signal team listing) (legacy imported affiliation; current appointment unverified) | $25K$25K – $50K | New York, New York |
Operations and support
Alona CochranOffice Manager & Executive Assistant |
Edward ChangScientific Advisory Board Member |
Howard FillitScientific Advisory Board Member |
Husseini ManjiScientific Advisory Board Member |
Lennart MuckeScientific Advisory Board Member |
Lin NingSenior Associate |
Maurizio FavaScientific Advisory Board Member |
Mei LiangVice President, Finance |
Michael WeinerScientific Advisory Board Member |
Michál de BeerAnalyst |
Pascal LevensohnExecutive Chairman |
Rudolph TanziScientific Advisory Board Member |
Usua AmanamSenior Associate |
Co-investing
Khosla Ventures
Mojo Vision$22M · 2023-04-05
Bionaut Labs$43M · 2022-11-28- Zebra Medical Vision$30M · 2018-06-07
Nanox (Zebra Medical)$30M · 2018-06-07
Atomwise$45M · 2018-03-07
Mojo$10M · Unknown date
Dementia Discovery Fund
Montara Therapeutics$20M · 2025-03-13
Montara Therapeutics$8M · 2024-07-30
QurAlis$88M · 2023-03-09
Cerevance$51M · 2023-02-13
QurAlis$42M · 2020-05-13
KdT Ventures
Montara Therapeutics$20M · 2025-03-13
Montara Therapeutics$8M · 2024-07-30
Motif Neurotech$18M · 2024-01-24
General Sense$— · 2022-06-30
TripleBlind$24M · 2021-10-18
TripleBlind$24M · 2021-10-18
TripleBlind$24M · 2021
Breakout Ventures
General Sense$— · 2022-06-30
Twelve$— · Unknown date
CytoVale$— · Unknown date
General Catalyst
TripleBlind$24M · 2021-10-18
TripleBlind$24M · 2021-10-18
TripleBlind$24M · 2021
INKEF Capital
Salvia BioElectronics$60M · 2025-05-27
QurAlis$88M · 2023-03-09
QurAlis$42M · 2020-05-13
MedCrypt$25M · 2022-11-01
MedCrypt$25M · 2022- Zebra Medical Vision$30M · 2018-06-07
KCRise Fund
TripleBlind$24M · 2021-10-18
TripleBlind$24M · 2021-10-18
TripleBlind$24M · 2021
Mission BioCapital
Progentos Therapeutics$65M · 2024-05-20
QurAlis$88M · 2023-03-09
QurAlis$42M · 2020-05-13
OurCrowd
Bionaut Labs$43M · 2022-11-28- Zebra Medical Vision$30M · 2018-06-07
Nanox (Zebra Medical)$30M · 2018-06-07
Wavemaker Three-Sixty Health
TripleBlind$24M · 2021-10-18
TripleBlind$24M · 2021-10-18
TripleBlind$24M · 2021
aMoon- Zebra Medical Vision$30M · 2018-06-07
Nanox (Zebra Medical)$30M · 2018-06-07
Intermountain Health- Zebra Medical Vision$30M · 2018-06-07
Nanox (Zebra Medical)$30M · 2018-06-07
TripleBlind$24M · 2021-10-18
TripleBlind$24M · 2021
Mojo Vision$22M · 2023-04-05
Mojo$10M · Unknown date
Prime Movers Lab
Paradromics$33M · 2023-05-18
Paradromics$20M · 2021-07-22
Two Bear Capital
Montara Therapeutics$20M · 2025-03-13
Montara Therapeutics$8M · 2024-07-30
Paradromics$33M · 2023-05-18
Paradromics$20M · 2021-07-22
Paradromics$20M · 2021-07-22
ALS Investment Fund
QurAlis$88M · 2023-03-09
Progentos Therapeutics$65M · 2024-05-20
Exciva€53M · 2026-01-20
Arboretum Ventures
Motif Neurotech$18M · 2024-01-24
Atlantic Bridge
Ubotica€4M · 2022-05-18
Baidu Ventures
Atomwise$45M · 2018-03-07
BEVC
Montara Therapeutics$20M · 2025-03-13
Capital Factory
Motif Neurotech$18M · 2024-01-24
CARMA FUND
Exciva€53M · 2026-01-20
Casdin Capital
Cerevance$20M · 2020-07-21
Compound
Bionaut Labs$43M · 2022-11-28
DFJ Growth
Atomwise$45M · 2018-03-07
Motif Neurotech$18M · 2024-01-24
Mojo Vision$22M · 2023-04-05
EIC Fund
Salvia BioElectronics$60M · 2025-05-27
Motif Neurotech$18M · 2024-01-24
Epidarex Capital
Libra Therapeutics$— · Unknown date
TripleBlind$24M · 2021-10-18
Progentos Therapeutics$65M · 2024-05-20
Fountain Healthcare Partners
Exciva€53M · 2026-01-20
Fusion Fund
Mojo Vision$22M · 2023-04-05
Future Ventures
Molten Salt Solutions$7M · 2026-08-31
Bionaut Labs$43M · 2022-11-28
Cerevance$51M · 2023-02-13
Gradient Ventures
Mojo$10M · Unknown date
Paradromics$33M · 2023-05-18
Hatteras Venture Partners
Sensorium Therapeutics$— · Unknown date
imec.xpand
Mojo$10M · Unknown date
Innovation Industries
Salvia BioElectronics$60M · 2025-05-27
Salvia BioElectronics$60M · 2025-05-27
Paradromics$20M · 2021-07-22
Exciva€53M · 2026-01-20
LifeArc Ventures
Exciva€53M · 2026-01-20
Cerevance$51M · 2023-02-13
Longwood Fund
Progentos Therapeutics$65M · 2024-05-20
Max Hodak
Motif Neurotech$18M · 2024-01-24
Mission Bay Capital
QurAlis$88M · 2023-03-09
NVentures
Nanox (Zebra Medical)$30M · 2018-06-07
Mojo Vision$22M · 2023-04-05
Panakès Partners
Salvia BioElectronics$60M · 2025-05-27
PsyMed Ventures
Motif Neurotech$18M · 2024-01-24
Paradromics$20M · 2021-07-22
Quentin Clark
TripleBlind$24M · 2021-10-18
re.Mind Capital
Motif Neurotech$18M · 2024-01-24
Richard Socher- Zebra Medical Vision$30M · 2018-06-07
Sands Capital
CytoVale$— · Unknown date
Sanofi Ventures
QurAlis$88M · 2023-03-09
Satori Neuro
Motif Neurotech$18M · 2024-01-24
Section 32
MedCrypt$25M · 2022-11-01
Ubotica€4M · 2022-05-18
SHS Capital
Salvia BioElectronics$60M · 2025-05-27
Bionaut Labs$43M · 2022-11-28
SOSV
General Sense$— · 2022-06-30
Paradromics$20M · 2021-07-22
Cerevance$51M · 2023-02-13
Tencent Investment
Atomwise$45M · 2018-03-07
Thuja Capital
Salvia BioElectronics$60M · 2025-05-27
Motif Neurotech$18M · 2024-01-24
Troy Wilson
Montara Therapeutics$20M · 2025-03-13
Upfront Ventures
Bionaut Labs$43M · 2022-11-28
Mojo$10M · Unknown date
Bionaut Labs$43M · 2022-11-28







































